Aided by Recent NIH Funding, OraLiva Prepares to Launch Oral Cancer Test

OraLiva, Inc. is preparing to launch its first noninvasive, AI-powered oral cancer test following recent NIH funding support. The test combines microfluidics, cytology, and advanced image analysis to detect mild-to-severe dysplasia earlier and more accurately than visual exams alone.